Conflict of interest: EVS, DJCG and HW work in the UK National Health Service (NHS). NHS Evidence – skin disorders is funded by the NHS. None of the authors has any financial connections with any pharmaceutical company.
Clinical dermatology • Review article
What’s new in acne? An analysis of systematic reviews published in 2009–2010
Article first published online: 25 AUG 2010
© 2010 The Author(s). © 2010 British Association of Dermatologists
Clinical and Experimental Dermatology
Volume 36, Issue 2, pages 119–123, March 2011
How to Cite
Smith, E. V., Grindlay, D. J. C. and Williams, H. C. (2011), What’s new in acne? An analysis of systematic reviews published in 2009–2010. Clinical and Experimental Dermatology, 36: 119–123. doi: 10.1111/j.1365-2230.2010.03921.x
A similar and more detailed review to the material published here appeared in the 2010 Annual Evidence Update on Acne published by NHS Evidence – skin disorders in March 2010 (http://www.library.nhs.uk/skin/ViewResource.aspx?resID=343542&tabID=289&catID=8275) and explicit reference is given to that fuller version throughout. There are no copyright issues with using material from that source.
- Issue published online: 16 FEB 2011
- Article first published online: 25 AUG 2010
- Accepted for publication 24 May 2010
- 13Isotretinoin and the risk of depression in patients with acne: a case crossover study. Pharmacoepidemiol Drug Saf 2006; 15: S261., , .
- 14Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev 2009 (3): CD004425., , et al.
- 15Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev 2009 (2): CD000194., , et al.